UMB Bank’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.5M Sell
107,194
-938
-0.9% -$124K 0.17% 99
2026
Q1
$15.1M Buy
108,132
+31
+0% +$4.34K 0.21% 87
2025
Q4
$13.3M Sell
108,101
-1,284
-1% -$156K 0.18% 102
2025
Q3
$12.1M Sell
109,385
-549
-0.5% -$62.4K 0.18% 96
2025
Q2
$12.2M Sell
109,934
-925
-0.8% -$98.4K 0.19% 99
2025
Q1
$12.4M Sell
110,859
-1,263
-1% -$130K 0.2% 97
2024
Q4
$10.4M Sell
112,122
-1,502
-1% -$135K 0.16% 108
2024
Q3
$9.53M Sell
113,624
-2,694
-2% -$206K 0.15% 116
2024
Q2
$7.98M Sell
116,318
-1,618
-1% -$108K 0.13% 126
2024
Q1
$8.64M Sell
117,936
-8,163
-6% -$628K 0.14% 129
2023
Q4
$10.2M Sell
126,099
-10,383
-8% -$808K 0.15% 117
2023
Q3
$10.2M Sell
136,482
-63,505
-32% -$4.88M 0.16% 117
2023
Q2
$15.4M Buy
199,987
+17,471
+10% +$1.39M 0.23% 88
2023
Q1
$15.1M Buy
182,516
+69,488
+61% +$5.76M 0.24% 92
2022
Q4
$9.7M Buy
113,028
+93,537
+480% +$7.41M 0.15% 129
2022
Q3
$1.2M Sell
19,491
-14,248
-42% -$898K 0.02% 314
2022
Q2
$2.08M Sell
33,739
-3,186
-9% -$197K 0.03% 276
2022
Q1
$2.19M Sell
36,925
-247
-0.7% -$15.8K 0.03% 285
2021
Q4
$2.7M Buy
37,172
+22,530
+154% +$1.55M 0.03% 262
2021
Q3
$1.02M Hold
14,642
0.02% 238
2021
Q2
$1.01M Buy
14,642
+392
+3% +$26.2K 0.02% 233
2021
Q1
$921K Buy
14,250
+1,680
+13% +$108K 0.02% 229
2020
Q4
$732K Sell
12,570
-85
-0.7% -$5.13K 0.02% 244
2020
Q3
$974K Hold
12,655
0.03% 208
2020
Q2
$974K Sell
12,655
-3,547
-22% -$272K 0.03% 208
2020
Q1
$1.21M Sell
16,202
-2,251
-12% -$156K 0.04% 194
2019
Q4
$1.2M Sell
18,453
-1,999
-10% -$130K 0.03% 206
2019
Q3
$1.3K Sell
20,452
-1,228
-6% -$80.3K 0.03% 204
2019
Q2
$1.46K Sell
21,680
-1,392
-6% -$91.6K 0.04% 195
2019
Q1
$1.5M Sell
23,072
-14,944
-39% -$993K 0.05% 191
2018
Q4
$2.38K Buy
38,016
+1,338
+4% +$93.5K 0.07% 148
2018
Q3
$2.83M Sell
36,678
-13,069
-26% -$987K 0.08% 146
2018
Q2
$3.52M Sell
49,747
-69,794
-58% -$4.93M 0.11% 133
2018
Q1
$9.01M Buy
119,541
+2,997
+3% +$238K 0.29% 83
2017
Q4
$8.35M Buy
116,544
+2,825
+2% +$215K 0.27% 81
2017
Q3
$9.21M Buy
113,719
+72,925
+179% +$5.58M 0.32% 79
2017
Q2
$2.89M Sell
40,794
-1,979
-5% -$132K 0.1% 140
2017
Q1
$2.9M Sell
42,773
-12,223
-22% -$859K 0.1% 143
2016
Q4
$3.94M Sell
54,996
-40,877
-43% -$3.04M 0.14% 118
2016
Q3
$7.58M Sell
95,873
-90,113
-48% -$7.32M 0.31% 77
2016
Q2
$15.5M Sell
185,986
-2,319
-1% -$206K 0.65% 51
2016
Q1
$17.3M Buy
188,305
+5,936
+3% +$535K 0.74% 42
2015
Q4
$18.5M Sell
182,369
-27,243
-13% -$2.83M 0.8% 32
2015
Q3
$20.6M Buy
209,612
+11,289
+6% +$1.25M 1.21% 15
2015
Q2
$23.2K Buy
198,323
+57,295
+41% +$6.26M 1.06% 14
2015
Q1
$13.8K Sell
141,028
-9,936
-7% -$1.01M 0.62% 41
2014
Q4
$14.2M Sell
150,964
-15,693
-9% -$1.62M 0.64% 37
2014
Q3
$17.7K Buy
166,657
+13,162
+9% +$1.29M 0.87% 24
2014
Q2
$12.7M Sell
153,495
-13,759
-8% -$1.07M 0.6% 39
2014
Q1
$11.9M Buy
167,254
+5,166
+3% +$405K 0.66% 44
2013
Q4
$12.2K Sell
162,088
-31,719
-16% -$2.21M 0.67% 42
2013
Q3
$12.2K Sell
193,807
-2,497
-1% -$149K 0.7% 34
2013
Q2
$10.1K Buy
+196,304
New +$10.2M 0.59% 45

Other funds holding GILD

UMB Bank's GILD Position: Q2 2026 in Review

UMB Bank reduced its Gilead Sciences (GILD) stake by 0.87% in Q2 2026, selling an estimated $124K and leaving 107,194 shares worth $13.5M. The position accounts for 0.17% of the portfolio, ranked #99.

UMB Bank first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $20.6M in Q3 2015. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • UMB Bank held 107,194 shares of Gilead Sciences worth $13.5M as of Q2 2026.
  • UMB Bank sold 938 Gilead Sciences shares in Q2 2026, an estimated $124K.
  • Gilead Sciences made up 0.17% of UMB Bank's portfolio in Q2 2026, its #99 holding.
  • UMB Bank first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
  • UMB Bank's Gilead Sciences position peaked at $20.6M in Q3 2015.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on UMB Bank's 13F filing for Q2 2026, filed 13 Aug 2026.